切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2026, Vol. 14 ›› Issue (02) : 123 -134. doi: 10.3877/cma.j.issn.2095-5782.2026.02.001

综述

栓塞材料的现有策略与未来展望
申知勋()   
  1. 05505 韩国首尔,蔚山大学医学院峨山医疗中心放射科及放射学研究所
  • 收稿日期:2026-03-03 出版日期:2026-05-25
  • 通信作者: 申知勋

Embolic Materials: A Comprehensive Review of Current Strategies and Future Perspectives

Ji Hoon Shin()   

  1. Department of Radiology and Research Institute of Radiology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul 05505, Korea
  • Received:2026-03-03 Published:2026-05-25
  • Corresponding author: Ji Hoon Shin
引用本文:

申知勋. 栓塞材料的现有策略与未来展望[J/OL]. 中华介入放射学电子杂志, 2026, 14(02): 123-134.

Ji Hoon Shin. Embolic Materials: A Comprehensive Review of Current Strategies and Future Perspectives[J/OL]. Chinese Journal of Interventional Radiology(Electronic Edition), 2026, 14(02): 123-134.

本文综述介入栓塞治疗中常用栓塞材料的类别、作用特点及应用要点,并概述相关新材料发展趋势,旨在为临床栓塞材料的个体化选择提供参考。栓塞术的临床疗效与并发症风险在很大程度上取决于栓塞材料的合理选择,需综合考虑闭塞持续时间、靶血管解剖与血流动力学特征以及具体治疗目标。近期研究重点集中在可快速溶解的栓塞剂,以避免长期缺血损伤。永久性栓塞技术已从金属弹簧圈和聚乙烯醇颗粒发展到精密的微球平台(含载药微球与可显影微球)。液体栓塞剂,如N-丁基氰基丙烯酸酯和乙烯-乙烯醇共聚物,实现了重大的范式转变,其能够不受固体颗粒的限制,深入渗透到远端微血管床。此外,乙醇作为关键的化学硬化剂,通过诱导内皮细胞即时坏死实现彻底闭塞。第二代水凝胶涂层弹簧圈和生物可吸收纤维的创新技术进一步提高了手术安全性和可预测性。随着血管内治疗向高精度介入发展,理解这些多样化的临时和永久材料对于在复杂的血管病变中优化患者预后和最小化并发症至关重要。

Embolization is a cornerstone of modern interventional radiology, offering minimally invasive treatments for hemorrhages, tumors, and vascular malformations. Clinical success depends on the strategic selection of agents based on vascular anatomy and therapeutic goals. This review comprehensively explores the transition from traditional materials to advanced biomaterials designed for specific clinical scenarios. Temporary strategies utilize gelatin sponge particles and resorbable microspheres to provide transient occlusion, with recent focus on quick soluble versions that prevent long term ischemic injury. Permanent embolization has evolved from metallic coils and polyvinyl alcohol particles to sophisticated microsphere platforms, including drug eluting and radiopaque beads. Liquid embolic systems, such as N butyl cyanoacrylate and ethylene vinyl alcohol copolymers, represent a significant paradigm shift by offering superior penetration into distal microvascular beds without the limitations of solid particles. Furthermore, ethanol remains a critical chemical sclerosant for definitive obliteration by inducing immediate endothelial destruction. Innovations like second generation hydrogel coated coils and bioabsorbable filaments further enhance procedural safety and predictability. As endovascular therapy moves toward high precision interventions, understanding these diverse temporary and permanent materials is essential for optimizing patient outcomes and minimizing complications in complex vascular landscapes.

表1 临时性与永久性栓塞剂的总结与比较
图1 68岁男性患者3 d出现黑便症状的空肠血管造影图 图1A、1B:因空肠溃疡经内镜夹闭治疗后仍持续出血,行选择性空肠血管造影,未见夹闭部位周围明显活动性出血。可见数条直血管横贯空肠(箭头所示);图1C:快速溶解明胶海绵颗粒(KIPZA;ENGAIN Co., Ltd., 韩国华城),提供多种规格,可在2 h内完全溶解。图1D、1E:经100~300 μm速溶明胶海绵颗粒进行选择性空肠分支栓塞后随访血管造影显示,穿行于空肠的直血管消失。随后成功止血,未见肠缺血或梗死征象。
Table 1. Summary and Comparison of Temporary and Permanent Embolic Agents
Embolic Agent Mechanism of Action Duration Key Advantages Major Limitations
Gelatin Sponge (GSP / QS-GSP) Scaffolding for intrinsic clot; enzymatic degradation. Days to Weeks (Hours for QS-GSP) Cost-effective; preserves long-term organ viability. Dependent on patient coagulation; unpredictable resorption.
Polyvinyl Alcohol (PVA) Mechanical wedging; triggers inflammatory fibrosis. Permanent (Late recanalization possible) Long track record; effective for non-selective occlusion. Tendency to aggregate; risk of proximal catheter clogging.
Microspheres (Tris-acryl / HepaSphere) Precise vascular caliber matching; drug loading. Permanent Highly predictable distal penetration; drug-eluting (DEB) capability. Higher cost compared to traditional PVA or GSP.
Metallic Coils (Platinum / Hydrogel) Physical scaffold inducing thrombus formation. Permanent Excellent radiopacity; precise controlled detachment. Risk of coil compaction; limited packing density in large spaces.
NBCA (Glue) Instant polymerization upon contact with ions (blood). Permanent Immediate hemostasis; effective regardless of coagulation status. High technical difficulty; risk of microcatheter adhesion.
EVOH (Onyx) Non-adhesive precipitation (outside-in solidification). Permanent Lava-like flow; deep penetration into complex AVMs/niduses. Requires DMSO-compatible catheters; tantalum imaging artifacts.
Ethanol Immediate endothelial dehydration & protein denaturation. Permanent (Definitive) Destroys the entire vessel wall; eliminates collateral recruitment. High systemic toxicity; intense pain (requires deep sedation).
Figure 1. A 68-year-old male patient presented with melena three days prior. (1A, 1B) Selective jejunal angiogram, performed due to persistent bleeding despite endoscopic clipping for a jejunal ulcer, shows no overt active bleeding around the clipping site. Several vasa recta are seen traversing the jejunum (arrows). (C) Quick-soluble gelatin sponge particles (KIPZA; ENGAIN Co., Ltd., Hwaseong, Republic of Korea), available in various sizes, which dissolve within 2 hours. (D, E) Follow-up angiography after selective jejunal branch embolization using 100-300 μm quick-soluble gelatin sponge particles shows the disappearance of the vasa recta traversing the jejunum. Hemostasis was subsequently achieved without signs of bowel ischemia or infarction.
[1]
Kim JH. Review of embolic materials for gastrointestinal bleeding embolization[J]. Int J Gastrointest Intervention, 2025, 14(3): 90-92.
[2]
Vaidya S, Tozer KR, Chen J. An overview of embolic agents[J]. Semin Intervent Radiol, 2008, 25(3): 204-215.
[3]
Ko G, Choi JW, Lee N, et al. Recent progress in liquid embolic agents[J]. Biomaterials, 2022, 287: 121634.
[4]
Bae S, Do YS, Shin SW, et al. Ethanol embolotherapy of pelvic arteriovenous malformations: an initial experience[J]. Korean J Radiol, 2008, 9(2): 148-154.
[5]
Whalen S, Tanious M. Temporary Embolic Agents[J]. Semin Intervent Radiol, 2024, 41(2): 226-232.
[6]
Kim JH, Jeon UB, Kim CW, et al. Characteristics and efficacy of fish-derived gelatin microparticles as an embolic agent in a rabbit renal model: regulation of the degradation period by molecular weight[J]. Diagn Interv Radiol, 2022, 28(1): 65-71.
[7]
Shin JH. Recent update of embolization of upper gastrointestinal tract bleeding[J]. Korean J Radiol, 2012, 13(Suppl 1): S31-S39.
[8]
Poursaid A, Jensen MM, Huo E, et al. Polymeric materials for embolic and chemoembolic applications[J]. J Control Release, 2016, 240: 414-433.
[9]
Alali M, Cao C, Shin JH, et al. Preliminary report on embolization with quick-soluble gelatin sponge particles for angiographically negative acute gastrointestinal bleeding[J]. Scientific Reports, 2024, 14(1): 6438.
[10]
Jeon CH, Yang SB, Yang WJ, et al. Embolization with quick-soluble gelatin sponge particles for lower gastrointestinal bleeding: a multicenter study[J]. Medicina (Kaunas), 2025, 61(11): 1964.
[11]
Wang CY, Hu J, Sheth RA, et al. Emerging embolic agents in endovascular embolization: an overview[J]. Prog Biomed Eng (Bristol), 2020, 2(1): 012003.
[12]
Liu L, Xu X, Zhu X, et al. Highly elastic polyvinyl alcohol embolic microspheres for effective transarterial embolization[J]. Mater Adv, 2025, 6(6): 2056-2070.
[13]
Li J, Xu J, Wang Y, et al. Fusible and radiopaque microspheres for embolization[J]. Adv Mater, 2024, 36(39): e2405224.
[14]
Wang Y, Ren Z, Wu H, et al. Ag2S/BaSO4/PVA embolic microspheres for precise localization, rapid embolization, and local antitumor therapy[J]. ACS Appl Mater Interfaces, 2024, 16(33): 43283-43301.
[15]
Nuzulia NA, Mart T, Ahmed I, et al. The use of microspheres for cancer embolization therapy: recent advancements and prospective[J]. ACS Biomater Sci Eng, 2024, 10(2): 637-656.
[16]
Laurent A, Beaujeux R, Wassef M, et al. Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation[J]. AJNR Am J Neuroradiol, 1996, 17(3): 533-540.
[17]
Spies JB, Cornell C, Worthington-Kirsch R, et al. Long-term outcome from uterine fibroid embolization with tris-acryl gelatin microspheres: results of a multicenter study[J]. J Vasc Interv Radiol, 2007, 18(2): 203-207.
[18]
Malagari K, Pomoni M, Moschouris H, et al. Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 μm. Safety and efficacy study[J]. Cardiovasc Intervent Radiol, 2014, 37(1): 165-175.
[19]
Ferral H. Hydrogel-coated coils: product description and clinical applications[J]. Semin Intervent Radiol, 2015, 32(4): 343-348.
[20]
Tsauo J. Embolization coils: materials, designs, and future directions[J]. Int J Gastrointest Intervention, 2025, 14(3): 93-97.
[21]
Koo HJ, Shin JH, Kim HJ, et al. Clinical outcome of transcatheter arterial embolization with N-butyl-2-cyanoacrylate for control of acute gastrointestinal tract bleeding[J]. AJR Am J Roentgenol, 2015, 204(3): 662-668.
[22]
Kolber MK, Shukla PA, Kumar A, et al. Ethylene vinyl alcohol copolymer (onyx) embolization for acute hemorrhage: a systematic review of peripheral applications[J]. J Vasc Interv Radiol, 2015, 26(6): 809-815.
[23]
Siskin GP, Rochon PJ, Gandhi R, et al. Peripheral vasculature embolization with the onyx liquid embolic system in a swine model[J]. J Vasc Interv Radiol, 2026, 37(1): 107815.
[24]
Jin L, Chun HJ, Oh JS, et al. Selective arterial embolization of renal angiomyolipoma: comparing ethanol-lipiodol emulsion and polyvinyl alcohol particles as embolic agents[J]. Diagn Interv Radiol, 2023, 29(1): 170-174.
[1] 焦瑞, 徐刚, 练慧斌, 殷志敏, 韩辉, 周杰. 骨盆骨折大出血患者动脉栓塞术后臀肌及皮肤坏死治疗方法的探讨[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(01): 7-11.
[2] 李丁洋, 党晓卫. 脾动脉部分栓塞术治疗门静脉高压症合并脾功能亢进的精准实践与策略[J/OL]. 中华普通外科学文献(电子版), 2026, 20(02): 79-84.
[3] 陈系东, 王绍闯, 赵何伟, 王硕, 袁维栋. 高龄BCLC B期肝癌患者常规TACE术后急性肝功能恶化的危险因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 689-692.
[4] 李婷婷, 李宏羽, 吴孟航. 肝动脉灌注化疗在不可切除肝细胞癌中的应用进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 705-708.
[5] 郑文涛, 肖静, 欧阳兵, 吴毅, 廖开友, 李春林. 载药微球CalliSpheres经支气管动脉化疗栓塞术治疗Ⅲ~Ⅳ期非小细胞肺癌疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(05): 691-696.
[6] 张龙, 徐伟, 孙善柯, 李文柱, 李俊达, 池涌泉, 宋进华, 王学浩, 成峰, 饶建华. 载药微球经动脉栓塞化疗在巨块型肝癌转化治疗中的疗效及安全性[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 28-35.
[7] 王艺, 程美雄, 徐如祥, 张天, 吴娅秋. Neuroform Atlas支架辅助弹簧圈栓塞治疗颅内宽颈动脉瘤的疗效分析[J/OL]. 中华脑科疾病与康复杂志(电子版), 2026, 16(02): 92-99.
[8] 高增霞, 贺云飞, 赵娜. DCE-MRI联合Gd-EOB-DTPA MRI纹理特征对肝细胞癌经导管动脉化疗栓塞术后疗效的评估[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(02): 108-113.
[9] 朱康, 郑潇, 张磊, 于娜. 超声造影及血清标志物检测对肝癌介入术后微血管侵犯及复发的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(05): 474-479.
[10] 李姁, 冯中秋. HBV相关原发性肝癌患者经导管动脉化疗栓塞术后严重腹痛预测模型的构建及验证[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(05): 480-485.
[11] 孙敬文, 程晓霞, 张晶晶, 倪国庆, 王剑. 超前镇痛模式在肝动脉化疗栓塞术围手术期的应用[J/OL]. 中华介入放射学电子杂志, 2026, 14(01): 55-59.
[12] 沈骁, 严海涛, 张金星, 祖庆泉, 刘圣, 施海彬. 基于MRI的影像组学预测TACE联合分子靶向药物及免疫检查点抑制剂治疗肝细胞癌疗效[J/OL]. 中华介入放射学电子杂志, 2026, 14(01): 72-80.
[13] 丘伟燕, 王治宇. 新生儿硬脑膜动静脉瘘行血管内栓塞术的手术护理配合一例[J/OL]. 中华介入放射学电子杂志, 2025, 13(04): 388-391.
[14] 翟浩琪, 宁波, 田卫国, 刘震宇, 高飞, 许展, 田帅, 令狐恩强. 一种基于内镜可喷洒止血材料止血性能评价[J/OL]. 中华胃肠内镜电子杂志, 2025, 12(04): 252-258.
[15] 令狐恩强. 超级微创切除实体肿瘤再认识[J/OL]. 中华胃肠内镜电子杂志, 2025, 12(04): 217-219.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?